Xu Wenjing, Nian Weiqi
Department of Oncology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China.
Front Oncol. 2023 Dec 5;13:1269735. doi: 10.3389/fonc.2023.1269735. eCollection 2023.
The 2019 novel coronavirus infection has done significant damage to the world. The effectiveness and safety of the vaccine, the most critical measure to control the epidemic, has attracted attention. In this case, we report the diagnosis and treatment of a rare patient with adverse effects of the COVID-19 vaccine who had G6PD deficiency by genetic tests. We discuss the possible impact of G6PD deficiency on COVID-19 infection and potential vaccine adverse effects. Patients with severe G6PD deficiency should be monitored for vaccine safety. This article may complement a rare mechanism of vaccine side effects and chemotherapy-related side effects.
2019新型冠状病毒感染给世界造成了重大破坏。疫苗作为控制疫情的最关键措施,其有效性和安全性备受关注。在此情况下,我们报告了1例经基因检测确诊为葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症的新型冠状病毒肺炎(COVID-19)疫苗不良反应罕见患者的诊疗情况。我们探讨了G6PD缺乏症对COVID-19感染及潜在疫苗不良反应的可能影响。对于严重G6PD缺乏症患者,应监测疫苗安全性。本文可能补充了一种罕见的疫苗副作用及化疗相关副作用机制。